对心力衰竭亚型的综合分析,在急诊室呈现急性心力衰竭管理
Journal of emergency nursing
|March 31, 2025
概括
心力衰竭亚型具有独特的临床和生物标志物概况. 在急诊室认识到这些差异可以改善患者风险分层和治疗结果.
科学领域:
- 心脏病学 心脏病学
- 紧急医疗 紧急医疗
- 生物标志物 生物标志物
背景情况:
- 尽管在诊断方面取得了进展,但跨心力衰竭类别 (减小,中等范围,保留喷射分数) 的病理生理复杂性仍然不完全理解.
- 这项研究的重点是描述患者呈现急性心力衰竭的急诊室在这三个亚型.
研究的目的:
- 分析和比较不同心力衰竭亚型患者的不同临床特征,心声回声测量和生物标志物概况.
- 识别可能存在的差异,这些差异可以为风险分层和在急诊室环境中量身定制的干预提供信息.
主要方法:
- 用电子健康记录对954名急性心力衰竭患者 (2016-2023) 的回顾性分析.
- 数据收集包括分拣,急诊室和住院信息.
- 卡普兰-梅尔生存分析和弹性网模型用于统计分析.
主要成果:
- 与其他亚型相比,心力衰竭患者具有保存的射出分数的年龄较大 (中位数为80岁).
- 心力衰竭的患者减少了喷射分数,表现出更高的心肌大病,多发性溢血,骨质疏松和NT-proBNP升高的流行率.
- 预测模型表现出强的性能:0.84 AUC在医院和0.80 AUC为30天的预测.
结论:
- 在心力衰竭亚型中存在不同的临床和生物标志物概况.
- 紧急护士对这些差异的认知可以增强风险分层,并指导量身定制的干预措施,改善患者的治疗结果.
- 将亚型特定数据集成到急诊室的协议中可以优化护理,特别是在长时间的患者登机期间.
更多相关视频
相关概念视频
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Heart Failure Drugs: β-Blockers
284
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
284
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
331
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
331
Heart Failure Drugs: Diuretics
298
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
298
Imaging Studies for Cardiovascular System II:Types of Echocardiography
211
Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
211
Heart Failure Drugs: Inotropic Agents
445
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
445


